The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets
Open accessAbstract
This work aims to employ fused deposition modelling 3D printing to fabricate immediate release pharmaceutical tablets with several model drugs. It investigates the addition of non-melting filler to methacrylic matrix to facilitate FDM 3D printing and explore the impact of (i) the nature of filler, (ii) compatibility with the gears of the 3D printer and iii) polymer: filler ratio on the 3D printing process. Amongst the investigated fillers in this work, directly compressible lactose, spray-dried lactose and microcrystalline cellulose showed a level of degradation at 135°C whilst talc and TCP allowed consistent flow of the filament and a successful 3D printing of the tablet. A specially developed universal filament based on pharmaceutically approved methacrylic polymer (Eudragit EPO) and thermally stable filler, TCP (tribasic calcium phosphate) was optimised. Four model drugs with different physicochemical properties were included into ready-to-use mechanically stable tablets with immediate release properties. Following the two thermal processes (hot melt extrusion (HME) and fused deposition modelling (FDM) 3D printing), drug contents were 94.22%, 88.53%, 96.51% and 93.04% for 5-ASA, captopril, theophylline and prednisolone respectively. XRPD indicated that a fraction of 5-ASA, theophylline and prednisolone remained crystalline whilst captopril was in amorphous form. By combining the advantages of thermally stable pharmaceutically approved polymers and fillers, this unique approach provides a low cost production method for on demand manufacturing of individualised dosage forms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Path to Personalized Medicine
Hamburg, M. A., & Collins, F. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1006304 · Cited by 1,970
Additive manufacturing and its societal impact: a literature review
Huang, S. H., Liu, P., Mokasdar, A., & Hou, L. (2013) · The International Journal of Advanced Manufacturing Technology · doi:10.1007/s00170-012-4558-5 · Cited by 1,862
A comparison of rapid prototyping technologies
Pham, D. T., & Gault, R. S. (1998) · International Journal of Machine Tools and Manufacture · doi:10.1016/s0890-6955(97)00137-5 · Cited by 915
Effect of geometry on drug release from 3D printed tablets
Goyanes, A., Robles Martinez, P., Buanz, A., Basit, A. W., & Gaisford, S. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.04.069 · Cited by 667
Genomic and personalized medicine: foundations and applications
Ginsburg, G. S., & Willard, H. F. (2009) · Translational Research · doi:10.1016/j.trsl.2009.09.005 · Cited by 637
Khaled, S. A., Burley, J. C., Alexander, M. R., Yang, J., & Roberts, C. J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.028 · Cited by 606
Fused-filament 3D printing (3DP) for fabrication of tablets
Goyanes, A., Buanz, A. B. M., Basit, A. W., & Gaisford, S. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.09.044 · Cited by 587
3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets
Goyanes, A., Buanz, A. B. M., Hatton, G. B., Gaisford, S., & Basit, A. W. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.12.003 · Cited by 570
Skowyra, J., Pietrzak, K., & Alhnan, M. A. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.11.009 · Cited by 530
Self-citationDesktop 3D printing of controlled release pharmaceutical bilayer tablets
Khaled, S. A., Burley, J. C., Alexander, M. R., & Roberts, C. J. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.11.021 · Cited by 511
Cited by
3D Printing in Pharmaceutical and Medical Applications – Recent Achievements and Challenges
Jamróz, W., Szafraniec, J., Kurek, M., & Jachowicz, R. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2454-x · Cited by 707
Channelled tablets: An innovative approach to accelerating drug release from 3D printed tablets
Sadia, M., Arafat, B., Ahmed, W., Forbes, R. T., & Alhnan, M. A. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.022 · Cited by 368
Self-citationAzad, M. A., Olawuni, D., Kimbell, G., Badruddoza, A. Z. M., Hossain, M. S., & Sultana, T. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020124 · Cited by 356
Goyanes, A., Fina, F., Martorana, A., Sedough, D., Gaisford, S., & Basit, A. W. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.05.021 · Cited by 355
Tan, D. K., Maniruzzaman, M., & Nokhodchi, A. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040203 · Cited by 329
Metadata
- Authors
- Sadia, M., Sośnicka, A., Arafat, B., Isreb, A., Ahmed, W., Kelarakis, A., & Alhnan, M. A.
- Venue
- International Journal of Pharmaceutics
- Publisher
- Elsevier BV
- Published
- 2016-11
- Volume
- 513
- Issue
- 1-2
- Pages
- 659-668
- ISSN
- 0378-5173 (ISSN-L)
- OpenAlex
- W2520634174
- Cited by
- 323
- References
- 33
- FWCI
- 27.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets. https://app.cochat.ai/papers/10.1016/j.ijpharm.2016.09.050
- The paper
- Sadia, M., Sośnicka, A., Arafat, B., Isreb, A., Ahmed, W., Kelarakis, A., & Alhnan, M. A. (2016). Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets. International Journal of Pharmaceutics. https://doi.org/10.1016/j.ijpharm.2016.09.050
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.